Clinical Trial Update: DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting [NA]

View source ↗

Summary

This entry covers a pilot clinical trial evaluating the safety of myocardial regeneration using direct epicardial shock wave therapy in combination with coronar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure with Reduced Ejection Fraction
• Ischemic Heart Disease

Snippet

Sponsor: Cardiac Regeneration Technologies, LLC | Conditions: Reduced Left Ventricular Function Defined as LVEF < 50%, Regional Left Ventricular Wall Motion Abnormalities | NA | Status: UNKNOWN